2 drug companies to pay $260M after jury finds them liable for city's opioid crisis [CBS News]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: CBS News
Jury deliberations began on Friday, Nov. 8, and concluded Tuesday afternoon. Following a six-week trial, the jury decided drug distributors McKesson and AmerisourceBergen would split the $266 million payment. During the trial, lawyers for the city argued that the two companies focused more on profit than public health and alleged the companies shipped millions of opioid pills into the city, ignoring their addictive properties. The oversupply of pills led residents to turn to more potent drugs like fentanyl and heroin, the city argued. The companies, on the other hand, argued they acted within their rights by selling approved painkillers to licensed pharmacies. During the trial, both companies denied any responsibility for any illegal drug trade. Lawyers for the city previously called this case the biggest and most important in Baltimore's history, The Baltimore Banner reported Featured Local Savings
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Wells Fargo & Company from $249.00 to $237.00. They now have an "equal weight" rating on the stock.MarketBeat
- Cencora Closes $1.8 Billion Senior Notes OfferingBusiness Wire
- Avalere Health welcomes Executive Vice President to fuse policy, access and marketing in a new offering [Yahoo! Finance]Yahoo! Finance
- Cencora, Inc. (NYSE: COR) is now covered by analysts at Mizuho. They set an "outperform" rating and a $280.00 price target on the stock.MarketBeat
- Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035Business Wire
COR
Earnings
- 11/6/24 - Beat
COR
Sec Filings
- 12/20/24 - Form 4
- 12/20/24 - Form 4
- 12/20/24 - Form 4
- COR's page on the SEC website